Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 9, 2013, Pages 3513-3518

  Bohr, Stefan ^a,b   Patel, Suraj J ^a,b   Shen, Keyue ^a,b   Vitalo, Antonia G ^a,b   Brines, Michael ^c   Cerami, Anthony ^c   Berthiaume, Francois ^d   Yarmush, Martin L ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c ARAIM PHARMACEUTICALS   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Cell adhesion molecules; Hypoxia; Leukocyte infiltration; Oxidative stress; Thermal injury

Indexed keywords

ARA 290; CD131 ANTIGEN; DERMATOLOGICAL AGENT; ERYTHROPOIETIN; HOMODIMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; DNA STRUCTURE; HEART INFARCTION; HEMORRHAGIC SHOCK; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SECONDARY PREVENTION; SIGNAL TRANSDUCTION; SKIN INJURY; SKIN TRANSPLANTATION; THROMBOSIS; TISSUE INJURY; TISSUE NECROSIS; WOUND;

ANIMALS; BURNS; CELL LINE; ERYTHROPOIETIN; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICROVESSELS; SIGNAL TRANSDUCTION; SKIN; THROMBOSIS; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 84874506651     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1214099110     Document Type: Article

References (39)

1. Lawrence JW, Mason ST, Schomer K, Klein MB (2012) Epidemiology and impact of scarring after burn injury: A systematic review of the literature. J Burn Care Res 33(1): 136-146.
2. Stroncek JD, ReichertWM (2008) Overview of wound healing in different tissue types. Indwelling Neural Implants: Strategies for Contending with the in Vivo Environment, ed Reichert WM (CRC, Boca Raton, FL).
3. Wilgus TA (2008) Immune cells in the healing skin wound: Influential players at each stage of repair. Pharmacol Res 58(2): 112-116.
4. Schwacha MG, Thobe BM, Daniel T, Hubbard WJ (2010) Impact of thermal injury on wound infiltration and the dermal inflammatory response. J Surg Res 158(1): 112-120.
5. Singer AJ, et al. (2010) Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: Acute-phase preservation of noninjured tissue and zone of stasis. J Burn Care Res 31(2): 304-309.
6. Nisanci M, Eski M, Sahin I, Ilgan S, Isik S (2010) Saving the zone of stasis in burns with activated protein C: An experimental study in rats. Burns 36(3): 397-402.
7. Posluszny JA, Jr., Conrad P, Halerz M, Shankar R, Gamelli RL (2011) Surgical burn wound infections and their clinical implications. J Burn Care Res 32(2): 324-333.
8. MosierMJ, Gibran NS (2009) Surgical excision of the burn wound. Clin Plast Surg 36(4): 617-625.
9. Swartjes M, et al. (2011) ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: An experimental study in rats and β-common receptor knockout mice. Anesthesiology 115(5): 1084-1092.
10. Huang X, et al. (2010) Erythropoietin receptor signaling regulates both erythropoiesis and megakaryopoiesis in vivo. Blood Cells Mol Dis 44(1): 1-6.
11. Beguin Y (1999) Erythropoietin and platelet production. Haematologica 84(6): 541-547.
12. Wolf RF, et al. (1997) Erythropoietin administration increases production and reactivity of platelets in dogs. Thromb Haemost 78(6): 1505-1509.
13. Villa P, et al. (2007) Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab 27(3): 552-563.
14. Brines M, et al. (2008) Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci USA 105(31): 10925-10930.
15. Boyle JJ (2005) Macrophage activation in atherosclerosis: Pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 3(1): 63-68.
16. Bernot D, Peiretti F, Canault M, Juhan-Vague I, Nalbone G (2005) Upregulation of TNF-alpha-induced ICAM-1 surface expression by adenylate cyclase-dependent pathway in human endothelial cells. J Cell Physiol 202(2): 434-441.
17. Bischof JC, et al. (1995) Dynamics of cell membrane permeability changes at supraphysiological temperatures. Biophys J 68(6): 2608-2614.
18. Merchant FA, Holmes WH, Capelli-Schellpfeffer M, Lee RC, Toner M (1998) Poloxamer 188 enhances functional recovery of lethally heat-shocked fibroblasts. J Surg Res 74(2): 131-140.
19. Kothari N, et al. (2011) Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. J Crit Care 26(4): 435.e431-437.
20. Galkowska H, Olszewski WL, Wojewodzka U (2005) Keratinocyte and dermal vascular endothelial cell capacities remain unimpaired in the margin of chronic venous ulcer. Arch Dermatol Res 296(7): 286-295.
21. Sese N, Cole M, Tawil B (2011) Proliferation of human keratinocytes and cocultured human keratinocytes and fibroblasts in three-dimensional fibrin constructs. Tissue Eng Part A 17(3-4): 429-437.
22. Gillis P, et al. (1999) Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J Cell Sci 112(Pt 12): 2049-2057.
23. Savla U, Waters CM (1998) Barrier function of airway epithelium: Effects of radiation and protection by keratinocyte growth factor. Radiat Res 150(2): 195-203.
24. Mak VH, et al. (1991) Barrier function of human keratinocyte cultures grown at the air-liquid interface. J Invest Dermatol 96(3): 323-327.
25. Pober JS (1999) Immunobiology of human vascular endothelium. Immunol Res 19(2-3): 225-232.
26. Bohr S, et al. (2013) Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound Repair Regen 21(1): 35-43.
27. Polgárová K, Lüthje P, Cerami A, Brauner A (2011) The erythropoietin analogue ARA290 modulates the innate immune response and reduces Escherichia coli invasion into urothelial cells. FEMS Immunol Med Microbiol 62(2): 190-196.
28. Pregi N, Wenker S, Vittori D, Leirós CP, Nesse A (2009) TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells. Exp Cell Res 315(3): 419-431.
29. Campana WM, et al. (2006) Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and pain-related behaviors after peripheral nerve injury. Eur J Neurosci 23(3): 617-626.
30. Taoufik E, et al. (2008) TNF receptor I sensitizes neurons to erythropoietin- and VEGFmediated neuroprotection after ischemic and excitotoxic injury. Proc Natl Acad Sci USA 105(16): 6185-6190.
31. Klemm K, et al. (2008) Multiple doses of erythropoietin impair liver regeneration by increasing TNF-alpha, the Bax to Bcl-xL ratio and apoptotic cell death. PLoS ONE 3(12): e3924.
32. Tobalem M, Harder Y, Schuster T, Rezaeian F, Wettstein R (2012) Erythropoietin in the prevention of experimental burn progression. Br J Surg 99(9): 1295-1303.
33. Galeano M, et al. (2006) Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds. Crit Care Med 34(4): 1139-1146.
34. Bader A, et al. (2012) Skin regeneration with conical and hair follicle structure of deep second-degree scalding injuries via combined expression of the EPO receptor and beta common receptor by local subcutaneous injection of nanosized rhEPO. Int J Nanomedicine 7: 1227-1237.
35. Sorg H, Harder Y, Krueger C, Reimers K, Vogt PM (2012) The nonhematopoietic effects of erythropoietin in skin regeneration and repair: From basic research to clinical use. Med Res Rev, 10.1002/med.21259.
36. Patel NS, et al. (2011) A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock. Mol Med 17(9-10): 883-892.
37. Furse RK, Kodys K, Zhu D, Miller-Graziano CL (1997) Increased monocyte TNF-alpha message stability contributes to trauma patients' increased TNF production. J Leukoc Biol 62(4): 524-534.
38. Segel GB, Halterman MW, Lichtman MA (2011) The paradox of the neutrophil's role in tissue injury. J Leukoc Biol 89(3): 359-372.
39. Ahmet I, et al. (2011) A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage. Mol Med 17(3-4): 194-200.